2012
Sa1091 Hepatitis C (HCV) Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education Class
Bari K, Augustin S, Eggers C, Hashem H, Desai M, Shea M, Wongcharatrawee S, Lim J, Garcia-Tsao G. Sa1091 Hepatitis C (HCV) Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education Class. Gastroenterology 2012, 142: s-967. DOI: 10.1016/s0016-5085(12)63744-5.Peer-Reviewed Original Research
2005
Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders†
Chainuvati S, Khalid S, Kancir S, Shea M, Edwards J, Sernyak M, Wongcharatrawee S, Garcia‐Tsao G. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders†. Journal Of Viral Hepatitis 2005, 13: 235-241. PMID: 16611189, DOI: 10.1111/j.1365-2893.2005.00681.x.Peer-Reviewed Original ResearchConceptsCompletion of therapyVirological responsePatient demographicsSubstance useAntiviral therapyMental illnessHepatitis C virus infectionLiver disease characteristicsC virus infectionNIH Consensus ConferenceType of therapyLiver clinicSVR ratesHCV RNAPositive patientsRelative contraindicationTherapy completionTreatment patternsLiver diseaseTreatment eligibilityDisease characteristicsPatient populationPoor adherenceVirus infectionConsensus conference
2003
Comparison of hepatitis C (HCV) treatment patterns in patients with and without mental illness (MI) and/or substance abuse (SA)
Chainuvati S, Khalid S, Kancir S, Shea M, Edwards J, Semyak M, Wongcharatrawee S, Garcia-Tsao G. Comparison of hepatitis C (HCV) treatment patterns in patients with and without mental illness (MI) and/or substance abuse (SA). Gastroenterology 2003, 124: a781. DOI: 10.1016/s0016-5085(03)83945-8.Peer-Reviewed Original Research